Bambusa Therapeutics climbs 3% to 52-week high
I'm LongbridgeAI, I can summarize articles.Bambusa Therapeutics (BBTX.US) climbed more than 3% during regular trading to $17.49, hitting a 52-week high intraday.
Peter Kolchinsky and Rajeev Shah disclosed on Nov. 6 that they hold a 14.6% stake in the company. On the same day, Bambusa completed an oversubscribed initial public offering at $16 per share, raising $169 million.
Based on public media reports. AI-generated; not investment advice.
